The impact of informed consent on patient interest in prostate-specific antigen screening.
about
Selling sickness: the pharmaceutical industry and disease mongering.What is lacking in current decision aids on cancer screening?Coaching and guidance with patient decision aids: A review of theoretical and empirical evidenceAre cancer-related decision aids appropriate for socially disadvantaged patients? A systematic review of US randomized controlled trials.Prostate cancer screening practices and beliefsTowards a philosophy of public health.Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening.Lack of comprehension of common prostate cancer terms in an underserved population.Decision aids for patients facing health treatment or screening decisions: systematic review.The development of a web- and a print-based decision aid for prostate cancer screening.Managing demand at the interface between primary and secondary care.The potential contribution of decision aids to screening programmes.Perceived ambiguity about cancer prevention recommendations: relationship to perceptions of cancer preventability, risk, and worryPerceived ambiguity about cancer prevention recommendations: associations with cancer-related perceptions and behaviours in a US population survey.Predictors of perceived ambiguity about cancer prevention recommendations: sociodemographic factors and mass media exposures.Does provision of an evidence-based information change public willingness to accept screening tests?Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-upRandomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviorsThe evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test.Informed decision making before initiating screening mammography: does it occur and does it make a difference?Screening in the dark: ethical considerations of providing screening tests to individuals when evidence is insufficient to support screening populationsPresentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study.Racial/ethnic differences in predictors of PSA screening in a tri-ethnic population.On what basis should the effectiveness of decision aids be judged?Randomised controlled trial of the effect of evidence based information on women's willingness to participate in cervical cancer screening.Development and application of patient decision aidsPatient education on prostate cancer screening and involvement in decision makingEliciting women's preferences in health care: a review of the literature.PSA testing: are patients aware of what lies ahead?Part 2: Patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing.Using prostate-specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer.Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study.Randomised controlled trial of an interactive multimedia decision aid on hormone replacement therapy in primary careA systematic review of information in decision aids.Fostering informed decisions: a randomized controlled trial assessing the impact of a decision aid among men registered to undergo mass screening for prostate cancerThe routine use of prostate-specific antigen for early detection of cancer prostate in India: Is it justified?Laypersons' responses to the communication of uncertainty regarding cancer risk estimates.Men's and carers' experiences of care for prostate cancer: a narrative literature reviewKnowledge, attitudes and experience associated with testing for prostate cancer: a comparison between male doctors and men in the community.Preparing African-American men in community primary care practices to decide whether or not to have prostate cancer screening.
P2860
Q22242090-95FA9084-062A-49C0-B2EC-FE9936392593Q26822925-183658EE-4DCC-4C1A-8C40-167D16422840Q26995811-D8D35AC2-FD7E-432E-9C25-6B1AF778F44AQ27307763-4695A5C2-5895-4950-9793-1F5C33647E54Q30309005-1A541A8B-2959-4ABB-9201-53E4B5A299EEQ30322188-DB9EFF4C-BA74-4FD3-A7D8-47CB33706B11Q30402074-A4262BB6-240A-47BF-BDCB-FC183E23085CQ30436410-92DF757F-5DCC-49D5-A28B-AD7A3D633C75Q30493146-45335BFC-C9BC-499C-9746-8769C66E02BFQ30493869-1F35DAAD-19F7-45B7-A28B-E6BE998A0C21Q33790757-B787F952-09F5-4D9F-9F74-B2B9942FB90EQ34255340-283426A8-5D8A-4005-AA74-0D7E13A5478BQ34324409-ACFE3FA7-F5F2-48D2-8EDE-0194F41D3621Q34344856-A5DA7F8A-6C55-4864-8428-5EB7A51C0C0FQ34393575-88305B98-9A88-4DA2-B784-41DED90CA7ADQ34514479-40ED5229-8C0F-4D0C-8875-72A840F3BE11Q34628065-39873B4C-59B6-4A1B-B08C-E261B60EFD19Q34733392-0757C8D5-CC45-4099-9654-89924B7BC2FCQ34743932-A574027C-1E53-41BF-ABDA-CE7FCEFAE9FBQ34902523-4B6B68FC-88DB-41CF-8488-4BC68CAB303DQ35046772-E414E34A-463F-40C8-938F-12C7E3B85996Q35132326-1A3F7DCA-189E-48EF-B499-99C1844449CAQ35189835-96849E8D-4897-4D31-B912-F91FE8CDCB47Q35206637-4BC34636-78E9-4189-BCEE-EF309F655154Q35412647-7D80DA37-4FCD-4488-9ECD-E4AD6AB2E854Q35603765-A0EA7AFC-3B85-4A70-94CA-8936F38B7C0EQ35721908-AF2781C9-8641-4BB0-AAD8-F83C1D7DBA13Q35812283-34FCAA93-2199-4A23-89F7-18DA86314E8EQ35968794-979321AA-DE04-4C17-A96C-D720B484D988Q36103676-02FB84C9-3147-4D4A-908C-62F9CEF5E162Q36432832-796ACBB4-CF8F-4818-A8EA-F453EADED00CQ36552760-6CF5224D-5185-4348-BA88-D9EAC8023DEBQ36745125-80B22725-A6A4-4E95-B133-D6896712388CQ36745730-264E6696-AE9F-43C1-853F-3782BFCEBFEBQ37055427-1545A232-23A9-4BE0-9AE7-E20C911E16C2Q37260341-EC30A64A-9E54-4FFD-A489-8075549ACC99Q37314726-DC98376D-A997-4687-8595-37B6BDB05EC5Q37332473-13B6DD3C-5CBB-46D3-B27C-2F768FDB974CQ39603999-8462D781-2DD1-469A-8938-4C16025FF734Q39730560-B02FD1B0-54C3-492A-841C-B685F554321E
P2860
The impact of informed consent on patient interest in prostate-specific antigen screening.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
The impact of informed consent ...... te-specific antigen screening.
@ast
The impact of informed consent ...... te-specific antigen screening.
@en
type
label
The impact of informed consent ...... te-specific antigen screening.
@ast
The impact of informed consent ...... te-specific antigen screening.
@en
prefLabel
The impact of informed consent ...... te-specific antigen screening.
@ast
The impact of informed consent ...... te-specific antigen screening.
@en
P2093
P1476
The impact of informed consent ...... te-specific antigen screening.
@en
P2093
P304
P356
10.1001/ARCHINTE.156.12.1333
P407
P577
1996-06-01T00:00:00Z